Viet Nam
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Viet Nam (VN)
2011 | 1.7 million |
2024 | 2.5 million |
2050 | 2.7 million |
Vietnam is one of the 37 countries and territories in the Western Pacific Region.
Data source(s) used for the diabetes estimates in adults:
- Duong Huong Phan, Trang Thu Vu t al. Medicine (Baltimore). 2022 Oct 14;101(41):e31149. doi: 10.1097/MD.0000000000031149. PMID:36253989
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 1,702.7 | 2,499.9 | 2,717.8 |
Age-standardised prevalence of diabetes, % | - | 3.2 | 3.4 | 3.5 |
Proportion of people with undiagnosed diabetes, % | - | - | 37.8 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 945.0 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 2,504.9 | 3,148.1 |
Age-standardised prevalence of IFG, % | - | - | 3.6 | 3.9 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 5,261.6 | 10,782.1 | 13,109.6 |
Age-standardised prevalence of IGT, % | - | 9.4 | 15.4 | 16.5 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 27,949.0 | 7,563.4 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 1.8 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | 274,091.2 | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | 21.0 | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | 4,537.2 | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | 7,466.0 | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 1,071.0 | 993.3 |
Total diabetes-related health expenditure, ID million | - | - | 3,108.0 | 2,882.3 |
Diabetes-related health expenditure per person, USD | - | 123.0 | 428.4 | 365.5 |
Diabetes-related health expenditure per person, ID | - | - | 1,243.3 | 1,060.5 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 23,100.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 7,016.2 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 58,408.1 | 69,065.9 | 77,479.5 |
Population of children and adolescents (0-19 y) | - | - | 30,764,394.5 | - |
Loading...
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |